These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30112174)

  • 21. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Favorable outcome of allogeneic hematopoietic stem cell transplantation followed by post-transplant treatment with imatinib in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Byun YJ; Suh JK; Lee SW; Lee D; Kim H; Choi ES; Koh KN; Im HJ; Seo JJ
    Blood Res; 2015 Sep; 50(3):147-53. PubMed ID: 26457281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era.
    Xue YJ; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1611-1620. PubMed ID: 30537550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic peripheral blood stem cell transplantation for treatment of induction failure in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Matsuishi E; Saito S; Miyamoto Y; Ota Y; Yoshitomi S; Niho Y; Harada M
    Int J Hematol; 1995 Jan; 61(1):43-7. PubMed ID: 7718769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustaining integrating imatinib and interferon-α into maintenance therapy improves survival of patients with Philadelphia positive acute lymphoblastic leukemia ineligible for allogeneic stem cell transplantation.
    Kuang P; Liu T; Pan L; Zhu H; Wu Y; Ye Y; Xiang B; Ma H; Chang H; Niu T; Cui X; He C; Li J; Ji J; Huang J; Dong T; Dai Y; Lu X; Qing S; Wu H; Liang X; Wang X; Wu C
    Leuk Lymphoma; 2016 Oct; 57(10):2321-9. PubMed ID: 26879808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Philadelphia chromosome positive acute lymphoblastic leukemia masquerading as persistent asymptomatic bone marrow necrosis.
    Kwong YL; Pollock A; Wei D; Lie AK
    Pathology; 1994 Apr; 26(2):183-5. PubMed ID: 8090591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extensive Bone Marrow Necrosis: A Rare Presentation of Acute Lymphoblastic Leukaemia.
    Ranathunga I; Muthumala NR; Kulathilake HWCK; Weerasinghe S; Shyamali NLA
    Case Rep Hematol; 2020; 2020():8889850. PubMed ID: 32908730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome.
    Thomas X; Thiebaut A; Olteanu N; Danaïla C; Charrin C; Archimbaud E; Fiere D
    Hematol Cell Ther; 1998 Jun; 40(3):119-28. PubMed ID: 9698220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic bone marrow transplantation in first remission rescues children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) studies L89-12 and L92-13.
    Mori T; Manabe A; Tsuchida M; Hanada R; Yabe H; Ohara A; Saito T; Nakazawa S
    Med Pediatr Oncol; 2001 Nov; 37(5):426-31. PubMed ID: 11745870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Glivec in combination with HA regimen for treatment of 20 patients with Ph chromosome positive acute leukemia].
    Meng FY; Zheng WY; Liu XL; Song LL; Xu B; Zhang Y; Huang F
    Ai Zheng; 2003 Aug; 22(8):840-3. PubMed ID: 12917031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bone marrow necrosis as a manifestation of leukemic relapse in a patient with bone marrow transplant].
    Rojas R; García Castellano JM; Gómez García P; Martínez Guibelalde F; Herrera C; Fornés G; Torres A
    Sangre (Barc); 1989 Jun; 34(3):238-40. PubMed ID: 2669187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dasatinib for a child with Philadelphia chromosome-positive acute lymphoblastic leukemia and persistently elevated minimal residual disease during imatinib therapy.
    Wu KH; Wu HP; Weng T; Peng CT; Chao YH
    Curr Oncol; 2015 Aug; 22(4):303-6. PubMed ID: 26300669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society.
    Espérou H; Boiron JM; Cayuela JM; Blanchet O; Kuentz M; Jouet JP; Milpied N; Cahn JY; Faucher C; Bourhis JH; Michallet M; Tanguy ML; Vernant JP; Gabert J; Bordigoni P; Ifrah N; Baruchel A; Dombret H;
    Bone Marrow Transplant; 2003 May; 31(10):909-18. PubMed ID: 12748668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imatinib combined chemotherapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: major challenges in current practice.
    Yanada M; Naoe T
    Leuk Lymphoma; 2006 Sep; 47(9):1747-53. PubMed ID: 17064984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperative Group SHOP studies ALL-94, ALL-99 and ALL-2005.
    Rives S; Estella J; Gómez P; López-Duarte M; de Miguel PG; Verdeguer A; Moreno MJ; Vivanco JL; Couselo JM; Fernández-Delgado R; Maldonado M; Tasso M; López-Ibor B; Lendínez F; López-Almaraz R; Uriz J; Melo M; Fernández-Teijeiro A; Rodríguez I; Badell I
    Br J Haematol; 2011 Sep; 154(5):600-11. PubMed ID: 21707583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lou Y; Ma Y; Li C; Suo S; Tong H; Qian W; Mai W; Meng H; Yu W; Mao L; Wei J; Xu W; Jin J
    Front Med; 2017 Jun; 11(2):229-238. PubMed ID: 28349299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Donor cell leukemia with bone marrow necrosis].
    Ikegawa S; Najima Y; Sano N; Horiguchi SI; Kaito S; Kurosawa S; Sakaguchi M; Harada K; Hino Y; Yamamoto K; Senoo Y; Watanabe D; Yoshioka K; Watakabe K; Igarashi A; Doki N; Kobayashi T; Kakihana K; Sakamaki H; Hishima T; Ohashi K
    Rinsho Ketsueki; 2016; 57(11):2334-2338. PubMed ID: 27941282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone Marrow Necrosis in Newly Diagnosed Acute Leukemia: Two Case Reports and Review of the Literature.
    Quintela A; Sujobert P; Tigaud I; Hayette S; Ffrench M; Salles G; Thomas X; Plesa A
    Oncol Ther; 2017; 5(1):111-118. PubMed ID: 28680961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era.
    Chen H; Liu KY; Xu LP; Chen YH; Zhang XH; Wang Y; Qin YZ; Liu YR; Lai YY; Huang XJ
    Leuk Res; 2017 Aug; 59():136-141. PubMed ID: 28654842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.